By Fink Densford
TransEnterix (NYSE:TRXC) said yesterday that it’s looking for $50 million from a follow-on offering of common stock to finance the sales and marketing of its SurgiBot robot-assisted surgery device.
The Research Triangle Park, N.C.-based company has not yet revealed the amount of shares, share price or date the offering will open.
Stifel and RBC Capital Markets will be book-runners on the offering, with Raymond James and BTIG as co-managers, TransEnterix said.
